LOAN AGREEMENT
THIS
LOAN
AGREEMENT (this “Agreement”),
is
executed as of April, 2007, by and between AuraSound, Inc. a California
corporation (the “Company”),
and
Clearview Partners, LLC, a Nevada limited liability corporation (the
“Lender”).
WHEREAS,
the Company is preparing to conduct a private placement offering (the
“Private
Placement”)
simultaneously with a reverse merger (the “Merger”)
with a
publicly traded shell company (the “Public
Company Parent”)
whereby the Company will become a wholly-owned subsidiary of the Public Company
Parent upon the consummation of the Merger;
WHEREAS,
in order to fund the Company’s operations until such Private Placement and
Merger are completed, the Company wishes to borrow $500,000 from the Lender
as a
short-term bridge loan to be repaid upon the consummation of the Private
Placement and the Merger;
WHEREAS,
the Lender is willing to provide such financing on terms and conditions as
set
forth herein; and
WHEREAS,
the Loan (as defined below) will not be secured by any of the assets of the
Company.
NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth
herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Lender,
intending to be legally bound, agree as follows:
ARTICLE
1
DEFINITIONS
1.1 Defined
terms.
Certain
capitalized terms used in this Agreement shall have the specific meanings
defined below:
“Business
Day”
shall
mean a day other than a Saturday, Sunday, or other day on which commercial
banks
are authorized or required by law to close.
“Common
Stock”
shall
mean the common stock of the Company.
“Default
Rate”
shall
mean the higher of (a) the highest prime rate of interest per annum published
in
the Money Rate Table of the Western Edition of The Wall Street Journal, as
adjusted on a daily basis, plus twelve and one-quarter percent (12.25%) per
annum, or (b) 20.00% per annum, in either case compounded annually. From and
after the occurrence of any Event of Default, the Default Rate shall
apply.
“Equity
Securities”
shall
mean the capital stock of such person or entity and/or any Stock Equivalents
of
such person or entity.
“Interest”
has
the
meaning set forth in Section 2.1.
“Interest
Rate”
shall
mean 12.00% compounded annually.
“Loan
Closing Date”
shall
mean the date upon which the Loan is made to the Company.
“Stock
Equivalents”
of
any
person or entity shall mean options, warrants, calls, rights, commitments,
convertible securities and other securities pursuant to which the holder,
directly or indirectly, has the right to acquire (with or without additional
consideration) capital stock or equity of such person or entity.
“Warrant”
has
the
meaning set forth in Section 7.1.
ARTICLE
2
THE
LOAN
2.1 Loan.
According to the terms and subject to the conditions of this Agreement, the
Lender shall make a loan to the Company on the Loan Closing Date in the amount
of $500,000 (the “Loan”).
The
Loan shall be evidenced by a promissory note in the form attached hereto as
Exhibit A
(the
“Note”),
duly
executed on behalf of the Company and dated as of the Loan Closing
Date.
2.2 Interest.
The
Loan shall bear interest (“Interest”)
from
the Loan Closing Date until the Maturity Date (as defined below) at the Interest
Rate (calculated on the basis of the actual number of days elapsed over a year
of 360 days). Interest is payable by the Company on a monthly basis in arrears
on the first Business Day of the month. Notwithstanding anything to the
contrary, in no event shall the Interest Rate be less than 12.00% per annum,
nor
shall the Interest Rate be adjusted to exceed the maximum amount permitted
by
applicable law.
2.3 Prepayment
of the Loan.
The
Company may from time to time prepay all or any portion of the Loan without
premium or penalty of any type. The Company shall give the Lender at least
three
Business Days prior written notice of its intention to prepay the Loan,
specifying the date of payment and the total amount of the Loan to be paid
on
such date. Once any portion of the Loan has been repaid, the funds may not
be
re-borrowed.
2.4 Maturity
Date.
Unless
the Loan is earlier accelerated pursuant to the terms hereof, the Loan and
all
accrued Interest thereon shall be due and payable in full on the earlier of
(i)
the date that is one hundred and twenty (120) days following the Loan Closing
Date; and (ii) the date on which the Company has received an aggregate of
$7,000,000 from the sale(s) of its Equity Securities, from and after the Loan
Closing Date, in one or a series of transactions (the “Maturity
Date”).
-2-
ARTICLE
3
CONDITIONS
PRECEDENT TO THE LOAN
3.1 Conditions
on the Loan Closing Date.
The
obligation of the Lender to make the Loan pursuant to Section 2.1 shall be
subject to the satisfaction, on or before the Loan Closing Date, of the
conditions set forth in this Section. If the conditions set forth in this
Section are not met on or prior to the Loan Closing Date, the Lender shall
have
no obligation to make the Loan.
(a) The
Company shall have duly executed and delivered to the Lender the Note
representing the Loan.
(b) There
shall exist no material adverse change in the condition (financial or
otherwise), results of operations, assets, properties or prospects of the
Company since September 30, 2006, the date of the most recent financial
statements provided to Lender, except for the Company’s receipt of bridge loans
totaling $2 million which are to repaid out of the proceeds of the Private
Placement along with the Loan.
(c) There
shall exist no material default in any of the Company’s obligations under any
contract or agreement.
(d) The
Company shall be in material compliance with all applicable laws.
(e) The
Company shall have retained Gemini Partners or GP Group, LLC as its exclusive
financial advisor in connection with the Merger, and shall provide evidence
of
such engagement.
(f) The
Lender shall have received such other documents, certificates, or other
materials as it reasonably requests from the Company with respect to the
transaction contemplated by Agreement and the Note.
ARTICLE
4
REPRESENTATIONS
AND WARRANTIES
4.1 Due
Incorporation and Good Standing.
The
Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of California with full and adequate power to carry
on and conduct its business as presently conducted, and is duly licensed or
qualified in all foreign jurisdictions wherein the failure to be so qualified
or
licensed would reasonably be expected to have a material adverse effect on
the
business of the Company.
4.2 Due
Authorization.
The
Company has full right, power and authority to enter into this Agreement, to
make the borrowings hereunder and execute and deliver the Note as provided
herein and to perform all of its duties and obligations under this Agreement
and
the Note. The execution and delivery of this Agreement and the Note will not,
nor will the observance or performance of any of the matters and things herein
or therein set forth, violate or contravene any provision of law or the
Company’s bylaws or certificate of incorporation. All necessary and appropriate
corporate action on the part of the Company has been taken to authorize the
execution and delivery of this Agreement and the Note. Concurrently with the
execution of this Agreement, the Company will deliver to the Lender a copy
of
the minutes of the meeting of the Company’s Board of Directors authorizing the
Company to enter into this Agreement and the Note , to make the borrowings
as
provided herein, and to perform all of its duties and obligations under this
Agreement and the Note and the .
-3-
4.3 Enforceability.
Each of
this Agreement and the Note has been validly executed and delivered by the
Company and constitutes the legal, valid and binding obligations of the Company
enforceable against it in accordance with its respective terms, subject to
applicable bankruptcy, insolvency, reorganization or similar laws relating
to or
affecting the enforcement of creditors’ right and to the availability of the
remedy of specific performance.
4.4 Capitalization.
All of
the Company’s authorized and outstanding Equity Securities are identified on
Schedule
A
attached
hereto. Other than as set forth on Schedule A,
there
are no outstanding shares of capital stock or any options, warrants or other
preemptive rights, rights of first refusal or similar rights to purchase Equity
Securities of the Company.
4.5 Subsidiaries.
The
Company owns no securities of any other entity, and there are no outstanding
shares of capital stock or any options, warrants or other preemptive rights,
rights of first refusal or similar rights to purchase equity securities of
any
other entity.
4.6 Compliance
with Laws.
The
nature and transaction of the Company’s business and operations and the use of
its properties and assets do not, and during the term of this Agreement shall
not, violate or conflict with in any material respect any applicable law,
statute, ordinance, rule, regulation or order of any kind or
nature.
4.7 Absence
of Conflicts.
The
execution, delivery and performance by the Company of this Agreement and the
Note, and the transactions contemplated hereby and thereby, do not constitute
a
breach or default, or require consents under, any agreement, permit, contract
or
other instrument to which the Company is a party, or by which the Company is
bound or to which any of the assets of the Company is subject, or any judgment,
order, writ, decree, authorization, license, rule, regulation, or statute to
which the Company is subject, except as contemplated in Section 3.1(b)
hereof.
4.8 Litigation
and Taxes.
There
is no litigation or governmental proceeding pending, or to the best knowledge
of
the Company after due inquiry, threatened, against the Company. The Company
has
duly filed all applicable income or other tax returns and has paid all material
income or other taxes when due. There is no controversy or objection pending,
or
to the best knowledge of the Company after due inquiry, threatened in respect
of
any tax returns of the Company.
4.9 No
Omissions or Misstatements.
None of
the information included in this Agreement, other documents or information
furnished or to be furnished by the Company contains any untrue statement of
a
material fact or is misleading in any material respect. Copies of all documents
referred to herein have been delivered or made available to the Lender and
constitute true and complete copies thereof and include all amendments,
schedules, appendices, supplements or modifications thereto or waivers
thereunder.
4.10 Financial
Statements.
The
financial statements of the Company provided to the Lender are complete and
correct as of the dates thereof and for the periods specified therein, have
been
prepared from the books and records of the Company in accordance with generally
accepted accounting principles consistently applied throughout the periods
involved, except for changes specified therein and except that unaudited
financial statements are not accompanied by notes, and present fairly the
financial condition, results of operations, shareholders’ equity and changes in
financial position of the Company as of the dates thereof and for the periods
specified therein.
-4-
4.11 Company
Knowledge and Experience.
The
Company (together with its accountants, legal counsel and other representatives
with whom it has consulted in connection with this Agreement) has such
knowledge, experience and access to professional advice in financial and
business matters, including loans like the Loan, to be capable of evaluating
the
risks and merits of receiving the Loan pursuant to this Agreement, and the
Company has obtained such professional third-party advice concerning the Loan
and the transactions contemplated hereby as it has desired and deemed
prudent.
ARTICLE
5
COVENANTS
5.1 Negative
Covenants of the Company.
The
Company covenants and agrees that, from the Loan Closing Date until the Maturity
Date (and, in any event, during such time as any portion of the Loan or any
Interest thereon is outstanding), without the consent of the Lender, the Company
will not:
(a) except
for the Merger, merge or consolidate with or into any other corporation or
sell
or otherwise convey 25% or more of its assets;
(b) in
a
single transaction or series of related transactions, effect a significant
acquisition of any business or entity (for purposes hereof, a “significant”
acquisition shall be determined in accordance with Instructions 2, 3 and 4
or
Item 2 of Form 8-K of the Securities and Exchange
Commission);
(c) engage
in
any business other than the business conducted by the Company on the Loan
Closing Date;
(d) declare,
set aside or pay any dividend or other distribution on any of its capital
stock;
(e) engage
in
any transaction with any Affiliate (as such term is defined in Rule 501(b)
of the Securities Act of 1933, as amended) on terms less favorable to the
Company than could be obtained from an unrelated party;
(f) amend
its
Articles of Incorporation or Bylaws in any manner that adversely affects the
rights associated with this Agreement or the Note; or
The
Company will give notice to the Lender of any default under any provisions
of
this Agreement within three business days after the discovery by the Company
of
such default.
-5-
5.2 Affirmative
Covenants of the Company.
The
Company covenants and agrees that, from the Loan Closing Date until the Maturity
Date (and, in any event, during such time as any portion of the Loan or any
Interest thereon is outstanding), the Company shall:
(a) operate
its business only in the ordinary course, maintain its properties and assets
in
good repair, working order and condition, and conduct all transactions with
third parties, including affiliates of the Company, on an arm’s length
basis;
(b) cause
to
be done all things reasonably necessary to maintain, preserve and renew its
corporate existence and all material licenses, authorizations and permits
necessary to the conduct of its businesses;
(c) comply
with all applicable laws, rules and regulations of all governmental authorities,
the violation of which could reasonably be expected to have a material adverse
effect on its business, properties or prospects;
(d) deliver
to the Lender within 45 days of the end of each fiscal quarter unaudited
consolidated financial statements (including balance sheets, statements of
income and loss, statements of cash flow and statements of shareholders’ equity)
all in reasonable detail, fairly presenting the financial position and the
results of operations of the Company as of the end of and through such periods,
prepared in accordance with generally accepted accounting principles,
consistently applied in the United States and consistent with past practice;
.
(e) deliver
to the Lender within five days after they are available (but in any event within
ninety days after the end of each of its fiscal years) the Company’s audited
annual financial statements and the Company’s annual budget, and allow the
Lender reasonable access during normal business hours to visit the Company
and
inspect the financial records of the Company; and
ARTICLE
6
DEFAULT
6.1 Events
of Default.
The
occurrence of any of the following events (each an “Event
of Default”),
not
cured in the applicable cure period, if any, shall constitute an Event of
Default of the Company:
(a) a
breach
of any representation, warranty, covenant or other provision of this Agreement,
or the Note, which, if capable of being cured, is not cured within seven days
following the earlier of (i) notice thereof to the Company and (ii) the Company
becoming aware of such breach;
(b) the
failure to make when due any payment described in this Agreement or the Note,
whether on or after the Maturity Date, by acceleration or otherwise;
(c) the
failure of the Public Company Parent to issue the Warrant; or
(d) (i) the
application for the appointment of a receiver or custodian for the Company
or
the property of the Company, or (ii) the entry of an order for relief or
the filing of a petition by or against the Company under the provisions of
any
bankruptcy or insolvency law, (iii) any assignment for the benefit of
creditors by or against the Company.
-6-
6.2 Effect
of Default.
Upon
the occurrence of any Event of Default that is not cured within any applicable
cure period, the Lender may elect, by written notice delivered to the Company,
to (i) declare this Agreement terminated and the outstanding amounts under
the Note to be forthwith due and payable, whereupon the entire unpaid Loan,
together with accrued and unpaid Interest thereon, and all other cash
obligations hereunder, shall become forthwith due and payable, without
presentment, demand, protest or any other notice of any kind, all of which
are
hereby expressly waived by the Company, anything contained herein or in the
Note
to the contrary notwithstanding, and (ii) exercise any and all other
remedies provided hereunder or available at law or in equity upon the occurrence
and continuation of an Event of Default. In addition, from and after the
expiration of the applicable cure period following the first Event of Default
until the entire unpaid principal amount of the Loan and all unpaid interest
thereon is paid or the Event of Default is cured if susceptible to cure,
Interest on the entire unpaid principal amount of the Loan and all unpaid
interest thereon shall accrue at the Default Interest Rate.
ARTICLE
7
WARRANT
7.1 Issuance
of Warrant.
The
Company shall cause the merger agreement for the Merger between the Company
and
Public Company Parent to include a covenant of the Public Company Parent that
it
will issue to the Lender at the closing of the Merger a Common Stock Purchase
Warrant (the "Warrant"),
in
form and substance reasonably acceptable to the Lender and the Company, having
substantially the following terms:
(a) The
number of shares for which the Warrant shall be exercisable shall be equal
to:
(i) 750,000 multiplied by (ii) a fraction, the numerator of which is $1.00
and
the denominator of which is the Lowest Equity Price. However, in the event
that
all or any portion of the Loan, all accrued Interest thereon and all other
sums
due hereunder, have not been received by Lender on or before the date that
is
one hundred twenty (120) days following the Loan Closing Date the number of
shares for which the Warrant shall be exercisable shall be equal to: (i)
1,500,000 multiplied by (ii) a fraction, the numerator of which is $1.00 and
the
denominator of which is the Lowest Equity Price.
(b) The
Initial Exercise Price (as defined in the Warrant) shall be the Lowest Equity
Price, rounded to the nearest cent;
(c) The
Warrant shall be exercisable only for cash.
(d) The
date
of the Warrant shall be the closing date of the Merger.
For
purposes of this Agreement, the "Lowest Equity Price" shall mean the lowest
price per share at which the Public Company Parent issues Equity Securities
from
the date hereof until the closing of the Merger in a transaction the primary
purpose of which is to raise capital
7.2 Public
Company Parent Issuance.
The
Company shall cause the Public Company Parent to issue the Warrant to the Lender
upon the closing of the Merger and will not allow the Public Company Parent
to
take any action that will interfere with the issuance of the Warrant on the
terms set forth in this Agreement.
-7-
7.3 Warrant
Obligations.
The
Company shall cause the Public Company Parent to comply on a timely basis with
each and every obligation under the Warrant.
7.4 Failure
to Complete Merger.
If
the Merger has not been completed before 270 days from the Loan Closing
Date:
(a) The
number of shares for which the Warrant shall be exercisable shall be equal
to:
(i) 750,000 multiplied by (ii) a fraction, the numerator of which is $1.00
and
the denominator of which is the lesser of (a) the Lowest Equity Price and (b)
the last price per share paid for the Company’s Common Stock prior to the Loan
Closing Date in
a
transaction the primary purpose of which was to raise capital,
rounded
to the nearest whole share;
(b) The
Initial Exercise Price (as defined in the Warrant) shall be the lower of
(a) the Lowest Equity Price and (b) the last price per share paid for the
Company’s Common Stock prior to the Loan Closing Date in a transaction the
primary purpose of which was to raise capital, rounded to the nearest cent;
7.5 Registration
Rights.
The
Lender shall have substantially the same registration rights with respect to
the
Warrant shares as provided to the investors in the Private
Placement.
ARTICLE
8
MISCELLANEOUS
8.1 Successors
and Assigns; Participations.
Subject
to the exceptions specifically set forth in this Agreement, the terms and
conditions of this Agreement shall inure to the benefit of and be binding upon
the respective executors, administrators, heirs, successors and assigns of
the
parties. This Agreement may be assigned solely by the Lender to any person
that
is not a competitor of the Company. Furthermore, although this Agreement and
the
Note name the Lender as the holder thereof and/or the lender thereunder, the
Lender is authorized to sell participation interests in the Loan to one or
more
other persons or entities that do not compete with the Company and that does
not
have an adverse claim against the Company. The Company agrees that: (a) each
holder of a participation interest will be entitled to rely on the terms of
this
Agreement and the Note as if such holder had been named as an original party
hereto and thereto; and (b) the Lender is authorized to provide all information
furnished by the Company to the Lender to each holder of a participation
interest.
8.2 Titles
and Subtitles.
The
titles and subtitles of the Sections of this Agreement are used for convenience
only and shall not be considered in construing or interpreting this
agreement.
-8-
8.3 Notices.
Any
notice, request or other communication required or permitted hereunder shall
be
in writing and shall be delivered personally or by facsimile (receipt confirmed
electronically) or shall be sent by a reputable express delivery service or
by
certified mail, postage prepaid with return receipt requested, addressed as
follows:
if
to Borrower, to:
Xxxxxx
Xxx
AuraSound,
Inc.
00000
Xxxx Xxxxx Xxx
Xxxxx
Xx Xxxxxxx, XX 00000
|
with
a copy to:
Xxxxx
Xxxxxxxxx
Xxxxxxxxxx
& Xxxxx, LLP
The
Chrysler Building
000
Xxxxxxxxx Xxxxxx, 00xx Xxxxx
Xxx
Xxxx, XX 00000
|
if
to the Lender, to:
Xxxx
Xxxxxx
Clearview
Partners, LLC
00000
Xxxxxx Xxxxx
Xxx
Xxxxxxx, XX 00000
|
with
a copy to:
Xxxxxxx
Xxxxxxx
Xxxxxxx
Xxxxx LLP
000
Xxxxxxxx Xxxxxx
Xxxxx
0000
Xxxxxx,
Xxxxx 00000
|
Either
party hereto may change the above specified recipient or mailing address by
notice to the other party given in the manner herein prescribed. All notices
shall be deemed given on the day when actually delivered as provided above
(if
delivered personally or by facsimile, provided that any such facsimile is
received during regular business hours at the recipient’s location) or on the
day shown on the return receipt (if delivered by mail or delivery
service).
8.4 Governing
Law; Venue.
This
Agreement shall be governed by and construed in accordance with the domestic
laws of the State of California without giving effect to any choice of law
or
conflict of law provision or rule (whether of the State of California or any
other jurisdiction) that would cause the application of the laws of any
jurisdiction other than the State of California. Any action arising out of
this
Agreement or the Note shall be brought in a state or federal court sitting
in
the City of Los Angeles, California.
8.5 Waiver
and Amendment.
Any
term of this Agreement may be amended, waived or modified with the written
consent of the Company and the Lender.
8.6 Remedies.
No
delay or omission by the Lender in exercising any of its rights, remedies,
powers or privileges hereunder or at law or in equity and no course of dealing
between the Lender and the undersigned or any other person shall be deemed
a
waiver by the Lender of any such rights, remedies, powers or privileges, even
if
such delay or omission is continuous or repeated, nor shall any single or
partial exercise of any right, remedy, power or privilege preclude any other
or
further exercise thereof by the Lender or the exercise of any other right,
remedy, power or privilege by the Lender. The rights and remedies of the Lender
described herein shall be cumulative and not restrictive of any other rights
or
remedies available under any other instrument, at law or in equity.
-9-
8.7 Expenses.
The
Company shall pay all customary costs and expenses incurred by the Lender in
connection with the negotiation and preparation of the documents contemplated
by
this Agreement and the Loan closing (including the Lender’s reasonable
attorneys’ fees), not to exceed $10,000.
8.8 Integration. This
Agreement, along with the Note, constitutes the complete and exclusive agreement
between the Company and the Lender with respect to the subject-matter herein
and
replaces and supersedes any and all other prior written and oral agreements
or
statements by such parties hereto relating to such subject-matter.
-10-
IN
WITNESS WHEREOF, the Company has caused this Loan Agreement to be signed in
its
name on the date first set forth above.
|
|
|
By: | /s/ Xxxx Xxxxxx | |
Xxxx
Xxxxxx
Managing
Director
Clearview
Partners, LLC
|
|
|
|
By: | /s/Xxxxxx Xxx | |
Xxxxxx
Xxx
Chief
Executive Officer
Aura
Sound, Inc.
|
||
-11-
SCHEDULE A
CAPITALIZATION
OF THE COMPANY
AuraSound
Capitalization Table
|
||||||||||
Outstanding
Shares
|
Issued
Options/Warrants
|
TOTAL
|
||||||||
Pre-Offering
Shareholders
|
||||||||||
Xxxxxx
Xxx
|
10,647,071
|
-
|
10,647,071
|
|||||||
Xxx
Xxxxxxxx
|
824,319
|
-
|
824,319
|
|||||||
Xxxxx
Xxxx
|
368,412
|
-
|
368,412
|
|||||||
Hazlaut
Investment
|
354,241
|
-
|
354,241
|
|||||||
Art
Xxxxxxxx
|
240,883
|
-
|
240,883
|
|||||||
Xxxxxx
Xxxxxxx
|
212,544
|
-
|
212,544
|
|||||||
Xxxxxx
Xxxxx
|
184,205
|
-
|
184,205
|
|||||||
Xxxx
Xxxxxxx
|
174,995
|
-
|
174,995
|
|||||||
Xxxxxx
Xxxxxxxx
|
143,114
|
-
|
143,114
|
|||||||
Xxxxxxx
Xxxxxxx
|
141,696
|
-
|
141,696
|
|||||||
Xxxxxxxx
Xxxxx
|
69,077
|
-
|
69,077
|
|||||||
Gemel
|
68,014
|
-
|
68,014
|
|||||||
TOTAL
|
13,428,571
|
-
|
13,428,571
|
The
Company’s authorized capital stock consists of 100,000,000 shares of Common
Stock, no par value per share.
Schedule
A-1
EXHIBIT A
PROMISSORY
NOTE
See
attached.
Exh
B-1